France orders divestitures in bio labs merger
Credit: Shutterstock/Alexander Raths
France’s Competition Authority has ordered medical laboratory Biogroup to divest three of its labs as a condition for its €500 million purchase of rival Laborizon.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now